首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Acid-labile pHPMA modification of four-arm oligoaminoamide pDNA polyplexes balances shielding and gene transfer activity in vitro and in vivo
【24h】

Acid-labile pHPMA modification of four-arm oligoaminoamide pDNA polyplexes balances shielding and gene transfer activity in vitro and in vivo

机译:四臂寡聚酰胺PDNA多方的耐酸性 - 寡聚酰胺PDNA多重余量屏蔽和基因转移活性在体外和体内

获取原文
获取原文并翻译 | 示例
           

摘要

We report novel pH-reversibly surface-shielded polyplexes with enhanced gene transfer activity upon systemic administration. A four-arm-structured sequence-defined cationic oligomer KK[HK[(H-Sph-K)(3)HC](2)](2) was designed and synthesized on solid-phase, containing additional lysine residues not only for improved pDNA polyplex stability, but also providing attachment points for subsequent polyplex functionalization with amine-reactive shielding polymers. Herein, the surface of polyplexes was shielded with hydrophilic polymers, monovalent PEG or monovalent and multivalent pHPMA, optionally attached to the polyplex via the acid-labile linker AzMMMan. Overall, surface modification with PEG or pHPMA resulted in a decrease in the zeta potential of polyplexes, consistent with the degree of surface shielding. At pH 6.0, only polyplexes modified via the acid-labile linkage showed an increase in zeta potential, consistent with a "deshielding" in acidic environment, expected as beneficial for endosomal escape. Shielding was more efficient for multivalent pHPMA (20 kDa, 30 kDa) as compared to monovalent pHPMA (10 kDa, 20 kDa, 30 kDa) or PEG (5 kDa). In vitro transfection studies revealed higher gene expression by the polyplexes with the acid-labile shield as compared to their irreversibly shielded counterparts. Intravenous administration of AzMMMan-pHPMA modified polyplexes in an in vivo tumor mouse model mediated enhanced gene expression in the subcutaneous tumor and reduced undesirable expression in the liver. (C) 2016 Elsevier B.V. All rights reserved.
机译:我们在全身施用时报告具有增强的基因转移活性的新型pH-可逆表面屏蔽的聚包。设计和合成了一种四臂结构序列定义的阳离子低聚物KK [HK [(H-SPH-K)(3)HC](2))并合成固相,不仅含有另外的赖氨酸残留物改善PDNA多重稳定性,而且还为随后的胺反应性屏蔽聚合物提供了用于随后的多分布官能化的附着点。在此,多用途的表面被亲水性聚合物,单价PEG或一价和多价PHPMA屏蔽,任选地通过酸性稳定连接器Azmmman与多种相连。总的来说,用PEG或PHPMA的表面改性导致Zeta电位的降低,与表面屏蔽的程度一致。在pH6.0时,仅通过酸性不稳定改性的多单双分布显示Zeta电位的增加,与酸性环境中的“脱离”一致,预计对内体逸出有益。与单价PHPMA(10kDa,20kDa,30kDa)或PEG(5kDa)相比,屏蔽对于多价pHPMA(20kDa,30kDa)更有效。与其不可逆屏蔽的对应物相比,体外转染研究揭示了多用用途与酸不稳定屏蔽的更高的基因表达。静脉内施用Azmmman-phPMA改性的多重聚合物在体内肿瘤小鼠模型中介导的皮下肿瘤中的增强基因表达,并降低了肝脏中的不希望的表达。 (c)2016年Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号